L. Holden

发表

E. Newlands, M. Stevens, G. Blackledge, 1985, Cancer treatment reports.

POMB/ACE chemotherapy for mediastinal germ cell tumours.

C. Brock, G. Rustin, M. Bower, 1997, European journal of cancer.

Secondary tumours following etoposide containing therapy for germ cell cancer.

C. Boshoff, J. Ong, G. Rustin, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of patients with poor prognosis anaplastic germ cell tumours (AGCT) of the testis and other sites.

S. M. Crawford, E. Newlands, G. Rustin, 1987, International journal of andrology.

Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.

M. Seckl, E. Newlands, G. Rustin, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.

G. Rustin, I. McNeish, M. Seckl, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours – a retrospective long-term follow-up study

M. Seckl, E. Newlands, G. Rustin, 2003, British Journal of Cancer.

Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors.

E. Newlands, G. Rustin, K. Bagshawe, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites

G. Rustin, M. Seckl, G. Rustin, 2007, International Journal of Gynecologic Cancer.

Chemotherapy for Malignant Ovarian Germ Cell Tumours

E. Newlands, G. Rustin, K. Bagshawe, 1985 .

Tumour Markers and POMB/ACE Chemotherapy in the Management of Ovarian Germ Cell Tumours (GCTs)

E. Newlands, K. Bagshawe, K. Bagshawe, 1988, The International journal of biological markers.

Current optimum management of anaplastic germ cell tumours of the testis and other sites.

S. M. Crawford, E. Newlands, G. Rustin, 1986, British journal of urology.

Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome

R. Woolas, M. Seckl, E. Newlands, 1998, British journal of obstetrics and gynaecology.

Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.

G. Rustin, I. McNeish, R. Agarwal, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy.

R H Begent, G. Rustin, M. Bower, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Management of brain metastases in patients with high-risk gestational trophoblastic tumors.

G. Rustin, I. McNeish, M. Seckl, 2002, The Journal of reproductive medicine.

Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989

E. Newlands, G. Rustin, R. Begent, 1992 .

Developments in chemotherapy for medium‐ and high‐risk patients with gestational trophoblastic tumours (1979–1984)

E. Newlands, G. Rustin, R. Begent, 1986, British journal of obstetrics and gynaecology.

Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options.

G. Rustin, M. Seckl, E. Newlands, 2000, European journal of cancer.

The management of high‐risk gestational trophoblastic tumours (GTT)

G J S Rustin, K D Bagshawe, E. Newlands, 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.

E S Newlands, R H Begent, K D Bagshawe, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation between clinical staging (FIGO) and prognostic groups with gestational trophoblastic disease

E. Newlands, K. Bagshawe, L. Holden, 1993, British journal of obstetrics and gynaecology.

Single agent etoposide in gestational trophoblastic tumours. Experience at Charing Cross Hospital 1978-1987.

E. Newlands, G. Rustin, R. Hitchins, 1988, European journal of cancer & clinical oncology.

The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.

G. Rustin, K. Bagshawe, J. Ledermann, 1994, British journal of urology.

Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989

E. Newlands, G. Rustin, K. Bagshawe, 1991, British journal of obstetrics and gynaecology.

Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years.

G. Rustin, E. Newlands, M. Bower, 1998, European journal of cancer.

Gestational trophoblastic disease with liver metastases: the Charing Cross experience

G. Rustin, R. A’Hern, E. Newlands, 1997, British journal of obstetrics and gynaecology.

Treatment of good-risk, stage II, non-seminomatous testis cancer

C. Boshoff, E. Newlands, T. Oliver, 1994, The Lancet.

Management of resistant gestational trophoblastic tumors.

M. Seckl, E. Newlands, G. Rustin, 1998, The Journal of reproductive medicine.

Chemotherapy for ovarian germ cell tumours.

G. Rustin, K. Fife, M. Bower, 1996, European journal of cancer.